ENTITY

Royalty Pharma (RPRX US)

16
Analysis
Health CareUnited States
Royalty Pharma plc acquires biopharmaceutical royalties. The Company funds innovation directly when it partners with companies to co-fund late-stage clinical trials and new product launches in exchange for future royalties, and indirectly when it acquires existing royalties from the original innovators.
more
Company Event11 Feb 2026 13:00 • Upcoming
Add To Calendar
Company Event04 Dec 2025 04:50 • Latest
Company Event03 Dec 2025 04:15
Company Event05 Nov 2025 21:00
x